You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TPST Buy Disclosure
Angel Matthew · SEC Form 4 · Filed Jun 23, 2026
Buy
Reported value range
Not reported
Angel Matthew CEO And President
TPST
Tempest Therapeutics
TPST
Transaction date
Mar 24, 2026
Public filing date
Jun 23, 2026
Filing lag
Filed 91 days later
TPST daily price context
Close on/before transaction
$1.75
Mar 24, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series A Warrant (right to buy) on Common Stock
- Quantity / price
- 231,482 shares
- SEC ownership
- Indirect
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001193125-26-279703
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$500K
Buys / sales
3 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Tempest Therapeutics, Inc. TPST | Buy | Mar 24, 2026 | $500K |
| Tempest Therapeutics, Inc. TPST Current | Buy | Mar 24, 2026 | Not reported |
| Tempest Therapeutics, Inc. TPST | Buy | Mar 24, 2026 | Not reported |